Vedtægter for ALK-Abelló A/S

March 27, 2013 09:35 ET | Source: ALK Abello ALK Abello

København, 2013-03-27 14:35 CET (GLOBE NEWSWIRE) -- Vedtægter for ALK-Abelló A/S med seneste ændringer vedtaget på den ordinære generalforsamling den 12. marts 2013.

Attachments

ALK_Vedtægter_12_03_2013 - final.pdf...

Recommended Reading

April 28, 2026 10:14 ET | Source: ALK Abello

Invitation to the presentation of ALK’s first quarter 2026 results on Tuesday, 5 May 2026

ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) will publish its results for the first quarter of 2026 in the morning on Tuesday, 5 May 2026. Later on the same day, the company will host a presentation for...
Read More
April 20, 2026 08:33 ET | Source: ALK Abello

ALK announces successful outcome of phase 2 trial with its tablet for treatment of peanut allergy demonstrating early onset of efficacy

Inside Information The ALLIANCE phase 2 trial demonstrated proof-of-concept after only 6 months of maintenance treatment in a broad patient population comprising both children and adults.Clear...
Read More